SCHOFIELD, Wis., July 11, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is announcing that leading headache researcher Dr. Roger Cady, MD will be exhibiting a poster presentation of his independent clinical study of PuraMed’s non-prescription migraine medication LipiGesic™ M at the 2011 Headache Update Conference being held at Disney’s Grand Floridian Resort & Spa in Orlando July 14-17, 2011. The study was recently published online in Headache, a top-tier medical journal of the American Headache Society, and is expected to be published in the printed version shortly.
